{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:09:28Z","timestamp":1790161768949,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005739","name":"UNAM-DGAPA","doi-asserted-by":"publisher","award":["IN209316"],"award-info":[{"award-number":["IN209316"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"UNAM-DGAPA","doi-asserted-by":"publisher","award":["IN216419"],"award-info":[{"award-number":["IN216419"]}],"id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["Fons Inst.\/58\/2016 and FC 2015-1\/115"],"award-info":[{"award-number":["Fons Inst.\/58\/2016 and FC 2015-1\/115"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.04.027","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T11:03:55Z","timestamp":1555326235000},"page":"5731-5737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Raw starch microparticles as BCG adjuvant: Their efficacy depends on the virulence of the infection strains"],"prefix":"10.1016","volume":"37","author":[{"given":"Silvia","family":"Moreno-Mendieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Barrera-Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce","family":"Mata-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Barrios-Pay\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogelio","family":"Hern\u00e1ndez-Pando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Rodr\u00edguez-Sanoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.04.027_b0005","unstructured":"Global Tuberculosis. 2017. <https:\/\/doi.org\/10.1001\/jama.2014.11450>."},{"key":"10.1016\/j.vaccine.2019.04.027_b0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tube.2015.06.004","article-title":"Type 2 diabetes - tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines","volume":"95","author":"Kumar","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2019.04.027_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.01.021","article-title":"The global tuberculosis situation and the inexorable rise of drug-resistant disease","volume":"102","author":"Marais","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2019.04.027_b0020","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.tube.2016.05.013","article-title":"TB vaccines in clinical development","volume":"99","author":"Ginsberg","year":"2016","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2019.04.027_b0025","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.autrev.2015.05.014","article-title":"On vaccine\u2019s adjuvants and autoimmunity: current evidence and future perspectives","volume":"14","author":"Pellegrino","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2019.04.027_b0030","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56: IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.027_b0035","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/21645515.2015.1023970","article-title":"A high ratio of IC31\u00ae adjuvant to antigen is necessary for H4 TB vaccine immunomodulation","volume":"11","author":"Aboutorabian","year":"2015","journal-title":"Hum Vacc Immunother"},{"key":"10.1016\/j.vaccine.2019.04.027_b0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2015.11.012","article-title":"Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates","volume":"102","author":"Agger","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2019.04.027_b0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/mi.2016.70","article-title":"Subunit vaccine H56\/CAF01 induces a population of circulating CD4 T cells that traffic into the Mycobacterium tuberculosis-infected lung","volume":"10","author":"Woodworth","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0050","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01Ein adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.027_b0055","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tube.2010.03.001","article-title":"Microparticles induce variable levels of activation in macrophages infected with mycobacterium tuberculosis","volume":"90","author":"Yadav","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2019.04.027_b0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/apm.12851","article-title":"Induction of strong immune response against a multicomponent antigen of mycobacterium tuberculosis in BALB\/c mice using PLGA and DOTAP adjuvant","volume":"126","author":"Khademi","year":"2018","journal-title":"Apmis"},{"key":"10.1016\/j.vaccine.2019.04.027_b0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.micpath.2018.05.035","article-title":"Are chitosan natural polymers suitable as adjuvant\/delivery system for anti-tuberculosis vaccines?","volume":"121","author":"Khademi","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2019.04.027_b0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1189\/jlb.4A0616-270R","article-title":"Rationalized design of a mucosal vaccine protects against mycobacterium tuberculosis challenge in mice","volume":"101","author":"Ahmed","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0075","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1021\/acs.molpharmaceut.6b00138","article-title":"Conjugation with an inulin-chitosan adjuvant markedly improves the immunogenicity of mycobacterium tuberculosis CFP10-TB10.4 fusion protein","volume":"13","author":"Yu","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2019.04.027_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09119-y","article-title":"Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection","volume":"7","author":"Counoupas","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2019.04.027_b0085","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1016\/j.vaccine.2017.08.012","article-title":"Raw starch microparticles have immunostimulant activity in mice vaccinated with BCG and challenged with Mycobacterium tuberculosis","volume":"35","author":"Moreno-Mendieta","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.027_b0090","first-page":"1718","article-title":"Mycobacterium bovis BCG substrains confer different levels of protection against mycobacterium tuberculosis infection in a BALB\/c model of progressive pulmonary tuberculosis","volume":"74","author":"Castillo-rodal","year":"2006","journal-title":"Society"},{"key":"10.1016\/j.vaccine.2019.04.027_b0095","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1128\/JCM.38.9.3200-3204.2000","article-title":"Molecular characterization of mycobacterium tuberculosis H37Rv\/Ra variants: distinguishing the mycobacterial laboratory strain","volume":"38","author":"Bifani","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.tube.2010.08.004","article-title":"Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission","volume":"90","author":"Aguilar","year":"2010","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2019.04.027_b0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2567.2008.03004.x","article-title":"Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model","volume":"128","author":"Marquina-Castillo","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.04.027_b0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.carbpol.2014.05.089","article-title":"Starch granules as a vehicle for the oral administration of immobilized antigens","volume":"112","author":"Guill\u00e9n","year":"2014","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.vaccine.2019.04.027_b0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1541-4337.2012.00193.x","article-title":"Rice starch diversity: effects on structural, morphological, thermal, and physicochemical properties-a review","volume":"11","author":"Wani","year":"2012","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"10.1016\/j.vaccine.2019.04.027_b0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2017.11.036","article-title":"Inhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregates","volume":"269","author":"Abdelaziz","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.04.027_b0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1574-695X.2009.00629.x","article-title":"Adjuvants in tuberculosis vaccine development","volume":"58","author":"Moreno-Mendieta","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14760584.2018.1406309","article-title":"Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?","volume":"17","author":"Khademi","year":"2018","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.04.027_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00407","article-title":"Immune responses to bacillus Calmette-Gu\u00e9rin vaccination: why do they fail to protect against mycobacterium tuberculosis?","volume":"8","author":"Moliva","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0140","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/eji.201646562","article-title":"Immunological consequences of strain variation within the Mycobacterium tuberculosis complex","volume":"47","author":"Tientcheu","year":"2017","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.vaccine.2014.11.004","article-title":"Effect of cationic liposomes on BCG trafficking and vaccine-induced immune responses following a subcutaneous immunization in mice","volume":"33","author":"Derrick","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.04.027_b0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2249.2003.02171.x","article-title":"A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes","volume":"133","author":"L\u00f3pez","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0155","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1128\/jcm.33.12.3234-3238.1995","article-title":"Predominnance of a single genotype of Mycobacterium tuberculosisin countries of East Asia","volume":"33","author":"van Soolingen","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.04.027_b0160","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3201\/eid0808.020002","article-title":"Worldwide occurrence of Beijing\/W strains of mycobacterium tuberculosis: a systematic review","volume":"8","author":"Glynn","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.04.027_b0165","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1128\/IAI.00443-12","article-title":"Innate immune gene polymorphisms in tuberculosis","volume":"80","author":"Azad","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.04.027_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2011.02.007","article-title":"Adjuvant effect of cationic liposomes and CpG depends on administration route","volume":"154","author":"Sl\u00fctter","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.04.027_b0175","doi-asserted-by":"crossref","first-page":"e1001307","DOI":"10.1371\/journal.ppat.1001307","article-title":"Human Macrophage Responses to Clinical Isolates from the Mycobacterium tuberculosis Complex Discriminate between Ancient and Modern Lineages","volume":"7","author":"Portevin","year":"2011","journal-title":"PLoS pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:12Z","timestamp":1759401312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19304785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19304785"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raw starch microparticles as BCG adjuvant: Their efficacy depends on the virulence of the infection strains","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}